Prediction model for drug response of acute myeloid leukemia patients

Despite some encouraging successes, predicting the therapy response of acute myeloid leukemia (AML) patients remains highly challenging due to tumor heterogeneity. Here we aim to develop and validate MDREAM, a robust ensemble-based prediction model for drug response in AML based on an integration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Trac, Quang Thinh, Pawitan, Yudi, Mou, Tian, Erkers, Tom, Östling, Päivi, Bohlin, Anna, Österroos, Albin, Vesterlund, Mattias, Jafari, Rozbeh, Siavelis, Ioannis, Bäckvall, Helena, Kiviluoto, Santeri, Orre, Lukas M., Rantalainen, Mattias, Lehtiö, Janne, Lehmann, Sören, Kallioniemi, Olli, Vu, Trung Nghia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039068/
https://www.ncbi.nlm.nih.gov/pubmed/36964195
http://dx.doi.org/10.1038/s41698-023-00374-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039068/
https://www.ncbi.nlm.nih.gov/pubmed/36964195
http://dx.doi.org/10.1038/s41698-023-00374-z

Ejemplares similares